Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome

The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome

(2012) A. Hoxha et al.   CLINICA CHIMICA ACTA

Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid Syndrome

(2012) Alexandru Vlagea et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS?

(2012) P Žigon et al.   LUPUS

Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome

(2012) A Hoxha et al.   LUPUS

Clinical significance of anti-annexin V antibody in acute cerebral ischemia

(2011) Kee Ook Lee et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus

(2011) MJ Adams et al.   LUPUS

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

(2010) V. Pengo et al.   THROMBOSIS RESEARCH

Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus

(2009) Peter Szodoray et al.   AUTOIMMUNITY

Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine–prothrombin complex: Identical or distinct diagnostic tools for antiphospholipid syndrome?

(2009) Troy D. Jaskowski et al.   CLINICA CHIMICA ACTA

Study of Phosphatidylserine-dependent Anti-prothrombin Antibody in Cerebral Infarction

(2009) Hirohisa Okuma et al.   INTERNAL MEDICINE

Anti-prothrombin antibodies are associated with thrombosis in children

(2009) Olof Rask et al.   THROMBOSIS RESEARCH